CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024
Operating expenses:
Research and development	$ 116,383	$ 214,447	$ 191,915	$ 457,449
General and administrative	849,182	1,253,070	2,492,345	2,781,683
Total operating expenses	965,565	1,467,517	2,684,260	3,239,132
Loss before other income (expense)	(965,565)	(1,467,517)	(2,684,260)	(3,239,132)
Interest income, net	7,740	43,084	16,902	99,409
Loss from continuing operations	(957,825)	(1,424,433)	(2,667,358)	(3,139,723)
Net loss	$ (957,825)	$ (1,424,433)	$ (2,667,358)	$ (3,139,723)
Loss per common share, basic ( in dollar per share)	$ (0.45)	$ (2.37)	$ (1.41)	$ (5.62)
Loss per common share, diluted ( in dollar per share)	$ (0.45)	$ (2.37)	$ (1.41)	$ (5.62)
Weighted average number of shares outstanding, basic (in shares)	2,122,872	600,417	1,892,399	558,518
Weighted average number of shares outstanding, diluted (in shares)	2,122,872	600,417	1,892,399	558,518